Malaria Vaccines Global Market Report 2024

Description

Malaria vaccines are specialized vaccines developed to prevent malaria, a potentially life-threatening infectious disease transmitted through mosquito bites and caused by parasites belonging to the Plasmodium genus. The primary objective of these vaccines is to confer immunity against the Plasmodium parasites, offering protection against the development of malaria.

The primary types of agents involved in malaria vaccines are Plasmodium falciparum, Plasmodium vivax, and Anopheles species. Plasmodium falciparum is a protozoan parasite accountable for the most severe and deadly form of malaria in humans. Various types of malaria vaccines include pre-erythrocytic, erythrocytic, multi-antigen, and others, and they can be administered through different routes such as intramuscular, subcutaneous, intradermal, among others. The distribution of these vaccines is facilitated through various channels, including both public and private avenues.

The malaria vaccines market research report is one of a series of new reports from The Business Research Company that provides malaria vaccines market statistics, including malaria vaccines industry global market size, regional shares, competitors with a malaria vaccines market share, detailed malaria vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the malaria vaccines industry. This malaria vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The malaria vaccines market size has grown exponentially in recent years. It will grow from $3.48 billion in 2023 to $4.7 billion in 2024 at a compound annual growth rate (CAGR) of 35.2%. The growth observed in the historic period in the field of malaria vaccines can be attributed to several factors, including the high burden of malaria, global health initiatives addressing the disease, funding and grants supporting research and development, malaria control programs, and government support and regulatory frameworks. These factors collectively contributed to advancements in the development and implementation of malaria vaccines during that period.

The malaria vaccines market size is expected to see exponential growth in the next few years. It will grow to $15.32 billion in 2028 at a compound annual growth rate (CAGR) of 34.3%. The anticipated growth in the forecast period in the field of malaria vaccines can be attributed to global efforts towards elimination goals, expanded access programs, a rise in vaccine coverage, global vaccine alliances, and the impact of climate change on the spread of malaria. Major trends expected in the forecast period include technological innovations in vaccine development, fostering public-private partnerships, promoting international collaboration, and advancements in vaccine technology. These trends are likely to shape and influence the progress and accessibility of malaria vaccines in the coming years.

The malaria vaccine market is anticipated to witness growth owing to an increase in mosquito-related diseases. These diseases, transmitted through mosquito bites, constitute a diverse range of illnesses. The RTS, S/AS01 (RTS, S) vaccine, a prominent player in the malaria vaccine market, is employed to prevent and mitigate the impact of mosquito-borne infectious diseases by training the immune system to recognize and combat the parasite. According to a November 2023 report from the World Health Organization (WHO), an estimated 249 million malaria cases occurred globally in 2022, reflecting a rise of 5 million cases from the previous year. Pakistan reported a significant increase, reaching an estimated 2.6 million cases in 2022 compared to 500,000 cases in 2021. The escalating incidence of mosquito-related diseases serves as a catalyst for the malaria vaccine market's growth.

Leading companies in the malaria vaccine market are actively innovating by developing products tailored for specific demographics, such as vaccines designed for children's malaria. This strategic approach aims to capture larger customer bases, boost sales, and augment revenue streams. Vaccines targeting mosquito-borne diseases are specialized immunological formulations offering protection against illnesses transmitted by mosquitoes. An exemplar in this category is a pediatric vaccine combating Plasmodium falciparum, the deadliest malaria parasite globally, and prevalent in Africa. In November 2022, Malawi and the World Health Organization (WHO) introduced Africa's inaugural children's malaria vaccine. The RTSS vaccine, tailored for young children, exhibits the potential to reduce mortality from the mosquito-borne disease. Despite a modest effectiveness rate of 30%, the vaccine, after pilot testing on over one million children in Ghana, Kenya, and Malawi, instills optimism for saving lives among the 400,000 individuals succumbing to malaria annually.

In August 2022, GlaxoSmithKline Plc, a prominent UK-based biopharmaceutical company, completed the acquisition of Affinivax Inc. for $3.3 billion. This strategic acquisition positions GlaxoSmithKline (GSK) to strengthen its pipeline of novel vaccines and enhance its presence in the Boston area, leveraging Affinivax Inc.'s innovative vaccine technology. Affinivax Inc., a US-based provider of vaccine technology, focuses on the development of malaria vaccines.

Major companies operating in the malaria vaccines market report are Pfizer Inc., Ipca Laboratories Ltd., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., Takeda Pharmaceutical Co Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Lupin, Taj Pharmaceuticals Limited., Nobelpharma Co. Ltd., Bliss GVS Pharma Ltd., Sanaria Inc., Precigen Inc., AdvaCare Pharma, CellFree Sciences, Actiza Pharmaceutical Private Limited, Sumaya Biotech, VLP Therapeutics LLC, GeoVax Labs Inc., Zydus Cadila, Genvec Inc.

North America was the largest region in the malaria vaccines market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the malaria vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The malaria vaccines market consists of sales of circumsporozoite protein (CSP) antigens, multi-component adjuvants, and circumsporozoite protein. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Malaria Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on malaria vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for malaria vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The malaria vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Agent: Plasmodium Falciparum; Plasmodium Vivax; Anopheles Species
2) By Vaccine Type: Pre-Erythrocytic; Erythrocytic; Multi-antigen; Other Vaccines
3) By Route of Administration: Intramuscular; Subcutaneous; Intradermal; Other Routes
4) By Distribution Channel: Public; Private
Companies Mentioned: Pfizer Inc.; Ipca Laboratories Ltd.; Novartis AG; Sanofi SA; GlaxoSmithKline Plc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r16492

1. Executive Summary

2. Malaria Vaccines Market Characteristics

3. Malaria Vaccines Market Trends And Strategies

4. Malaria Vaccines Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Malaria Vaccines Market Size and Growth

5.1. Global Malaria Vaccines Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Malaria Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Malaria Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Malaria Vaccines Market Segmentation

6.1. Global Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Plasmodium Falciparum
Plasmodium Vivax
Anopheles Species
6.2. Global Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pre-Erythrocytic
Erythrocytic
Multi-antigen
Other Vaccines
6.3. Global Malaria Vaccines Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Intramuscular
Subcutaneous
Intradermal
Other Routes
6.4. Global Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Public
Private

7. Malaria Vaccines Market Regional And Country Analysis

7.1. Global Malaria Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Malaria Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Malaria Vaccines Market

8.1. Asia-Pacific Malaria Vaccines Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Malaria Vaccines Market

9.1. China Malaria Vaccines Market Overview
9.2. China Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Malaria Vaccines Market

10.1. India Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Malaria Vaccines Market

11.1. Japan Malaria Vaccines Market Overview
11.2. Japan Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Malaria Vaccines Market

12.1. Australia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Malaria Vaccines Market

13.1. Indonesia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Malaria Vaccines Market

14.1. South Korea Malaria Vaccines Market Overview
14.2. South Korea Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Malaria Vaccines Market

15.1. Western Europe Malaria Vaccines Market Overview
15.2. Western Europe Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Malaria Vaccines Market

16.1. UK Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Malaria Vaccines Market

17.1. Germany Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Malaria Vaccines Market

18.1. France Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Malaria Vaccines Market

19.1. Italy Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Malaria Vaccines Market

20.1. Spain Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Malaria Vaccines Market

21.1. Eastern Europe Malaria Vaccines Market Overview
21.2. Eastern Europe Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Malaria Vaccines Market

22.1. Russia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Malaria Vaccines Market

23.1. North America Malaria Vaccines Market Overview
23.2. North America Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Malaria Vaccines Market

24.1. USA Malaria Vaccines Market Overview
24.2. USA Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Malaria Vaccines Market

25.1. Canada Malaria Vaccines Market Overview
25.2. Canada Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Malaria Vaccines Market

26.1. South America Malaria Vaccines Market Overview
26.2. South America Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Malaria Vaccines Market

27.1. Brazil Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Malaria Vaccines Market

28.1. Middle East Malaria Vaccines Market Overview
28.2. Middle East Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Malaria Vaccines Market

29.1. Africa Malaria Vaccines Market Overview
29.2. Africa Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Malaria Vaccines Market Competitive Landscape And Company Profiles

30.1. Malaria Vaccines Market Competitive Landscape
30.2. Malaria Vaccines Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Ipca Laboratories Ltd.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Novartis AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Sanofi SA
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. GlaxoSmithKline Plc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Malaria Vaccines Market Other Major And Innovative Companies

31.1. Takeda Pharmaceutical Co Ltd.
31.2. Hikma Pharmaceuticals PLC
31.3. Amneal Pharmaceuticals LLC.
31.4. Lupin
31.5. Taj Pharmaceuticals Limited.
31.6. Nobelpharma Co. Ltd.
31.7. Bliss GVS Pharma Ltd.
31.8. Sanaria Inc.
31.9. Precigen Inc.
31.10. AdvaCare Pharma
31.11. CellFree Sciences
31.12. Actiza Pharmaceutical Private Limited
31.13. Sumaya Biotech
31.14. VLP Therapeutics LLC
31.15. GeoVax Labs Inc.

32. Global Malaria Vaccines Market Competitive Benchmarking

33. Global Malaria Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Malaria Vaccines Market

35. Malaria Vaccines Market Future Outlook and Potential Analysis

35.1 Malaria Vaccines Market In 2028 - Countries Offering Most New Opportunities
35.2 Malaria Vaccines Market In 2028 - Segments Offering Most New Opportunities
35.3 Malaria Vaccines Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer